Skip to main content

Standard-Criteria Kidney Transplant Offers Clear Survival Benefit Over Continued Dialysis

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on June 10, 2025.

via HealthDay

TUESDAY, June 10, 2025 -- Transplantation with standard-criteria kidney offers a clear survival benefit, but this decreases with age and for those with a history of cardiovascular disease (CVD), according to a study presented at the annual congress of the European Renal Association, held from June 4 to 7 in Vienna.

Rachel Hellemans, M.D., Ph.D., from Antwerp University Hospital in Belgium, and colleagues examined the survival benefit of deceased donor kidney transplantation compared with continued dialysis in waitlisted patients with kidney failure. Data were included for 64,013 patients aged ≥20 years from the European Renal Association Registry database who were on dialysis while waitlisted for a first deceased donor kidney-only transplant.

Overall, 40,441 patients received a kidney transplant, either from a standard criteria donor (SCD)/donation after brain death (DBD), SCD/donation after circulatory death (DCD), expanded criteria donor (ECD)/DBD, or ECD/DCD (45.0, 12.1, 35.2, and 7.7 percent, respectively). The researchers found that higher five-year survival was seen in SCD transplant recipients versus dialysis patients. There was a decrease in survival benefits seen with age in ECD kidney transplant recipients, especially in recipients of DCD kidneys and recipients with CVD comorbidity: five-year survival was 57 and 58 percent for a 75-year-old ECD/DCD recipient or a 75-year-old ECD recipient with CVD, respectively, compared with 54 percent among patients continuing dialysis. In the oldest patients, early posttransplant mortality contributed to the reduced benefit.

"We found that transplantation with standard-criteria kidneys still offers a clear survival benefit at virtually every age, but in the oldest, most comorbid recipients receiving lower-quality organs, that edge can all but disappear," Hellemans said in a statement.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Increased Risk for CVD Seen for Women With Premenstrual Disorders

THURSDAY, July 17, 2025 -- Women with premenstrual disorders (PMDs) have an increased risk for cardiovascular diseases (CVDs), according to a study published online July 11 in...

Cell Therapy MDR-101 Produces Functional Immune Tolerance in Kidney Transplant Recipients

TUESDAY, July 15, 2025 -- Kidney transplant recipients receiving the investigational cellular product MDR-101 achieved functional immune tolerance for more than two years...

Public Health Response Data Show Success of Standard Infection Control Measures for Dialysis

MONDAY, July 14, 2025 -- Adherence to standard dialysis infection prevention and control (IPC) measures enabled safe provision of dialysis to patients with Candida auris...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.